The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(1R,5S,7R)-3-benzyl-7-(thiomorpholine-4-carbonyl)-6,8-dioxa-3-azabicyclo[3.2.1]octan-2-one ID: ALA589074
PubChem CID: 46229300
Max Phase: Preclinical
Molecular Formula: C17H20N2O4S
Molecular Weight: 348.42
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C([C@@H]1O[C@H]2CN(Cc3ccccc3)C(=O)[C@@H]1O2)N1CCSCC1
Standard InChI: InChI=1S/C17H20N2O4S/c20-16(18-6-8-24-9-7-18)14-15-17(21)19(11-13(22-14)23-15)10-12-4-2-1-3-5-12/h1-5,13-15H,6-11H2/t13-,14-,15-/m1/s1
Standard InChI Key: VOJVZLFJVXKZSY-RBSFLKMASA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
16.1165 -2.1862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9125 -1.9843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5729 -2.4820 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.7775 -2.9404 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.5984 -3.3055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1565 -3.6748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9669 -3.8342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3204 -3.7100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3310 -4.5349 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.0295 -3.2884 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5708 -2.8792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.9528 -2.9627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5598 -3.6880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7344 -3.7061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3414 -4.4306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7731 -5.1346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6020 -5.1096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9913 -4.3846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6609 -4.3344 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.9083 -1.1583 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
16.9625 -4.6583 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
19.7521 -3.6960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4591 -3.2779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4527 -2.4525 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
19.7332 -2.0471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0199 -2.4669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
12 13 1 0
5 7 1 0
13 14 2 0
6 7 1 0
14 15 1 0
1 4 1 0
15 16 2 0
16 17 1 0
3 5 1 0
17 18 2 0
18 13 1 0
8 9 2 0
6 19 2 0
8 10 1 0
2 20 1 1
5 8 1 1
7 21 1 1
10 22 1 0
2 3 1 0
7 11 1 0
2 11 1 0
4 6 1 0
4 12 1 0
10 26 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 348.42Molecular Weight (Monoisotopic): 348.1144AlogP: 0.71#Rotatable Bonds: 3Polar Surface Area: 59.08Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.07CX Basic pKa: ┄CX LogP: 0.81CX LogD: 0.81Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.81Np Likeness Score: -0.78
References 1. Trabocchi A, Mannino C, Machetti F, De Bernardis F, Arancia S, Cauda R, Cassone A, Guarna A.. (2010) Identification of inhibitors of drug-resistant Candida albicans strains from a library of bicyclic peptidomimetic compounds., 53 (6): [PMID:20184325 ] [10.1021/jm901734u ]